臨床研究等提出・公開システム

Date of registration	Mar. 07, 2017
Last modified on	Feb. 27, 2020
Trial ID	jRCT1080223473

Scientific Title	Clinical research for disease evaluation of Endometriosis
Public Title	Research for disease evaluation of Endometriosis

Completion Date or Terminated date	Oct. 09, 2019
Actual Enrolled Number
Baseline Characteristics
Participant flow
Adverse events
Primary Outcome Measures
Secondary Outcome Measures
Brief summary
Posting of journal publication
Date of the first journal publication of results
URL hyperlink(s) related to results and publications

Plan to share IPD	Yes
Plan description	Qualified researchers may request access to individual patient level data through the clinical study data request platform (www.clinicalstudydatarequest.com). For further details on Chugai's Data Sharing Policy and how to request access to related clinical study documents, see here (www.chugai-pharm.co.jp/english/profile/rd/ctds_request.html).
URL link to protocol file(s)
Version of protocol file(s)	version: date:

Contact for Scientific Queries	Name
	Contact Name for Scientific Queries	Chugai Pharmaceutical Co., Ltd.
	Address
	Phone Number
	E-mail Address	clinical-trials@chugai-pharm.co.jp

Contact for Public Queries	Name
	Contact Name for Public Queries	Chugai Pharmaceutical Co., Ltd.
	Address
	Phone Number
	E-mail Address	clinical-trials@chugai-pharm.co.jp

Recruitment Status	completed

Date of First Enrolment
Target Sample Size		80
Study Type		Observational
Study Design	Study Design	Prospective observational research
Study Design	Objective	diagnostic purpose
Phase		N/A
Key inclusion & exclusion criteria	Inclusion Criteria	Endometriosis
	Exclusion Criteria	The subject unsuitable for research participation in the judgment of the investigator
	Minimum Age	20age old over
	Maximum Age	No limit
	Gender	Female
Health Condition or Problem Studied		Endometriosis
Intervention(s)		investigational material(s) Generic name etc : - INN of investigational material : - Therapeutic category code : --- Other Dosage and Administration for Investigational material : - control material(s) Generic name etc : - INN of investigational material : - Therapeutic category code : Dosage and Administration for Investigational material : -
Health Condition(s) Keyword
Intervention(s) Keyword
Health Condition(s) Code
Intervention(s) Code
Primary Outcome		exploratory Evaluation of Endometriosis Imaging
Secondary Outcome		-

Primary Sponsor	CHUGAI PHARMACEUTICAL CO., LTD.
Secondary Sponsor	-

Name of Funding Organization	-
Name of Research Funding	-

Name	-
Address	-
Phone Number	-
E-mail Address	-
Status of Review	Approval
Date of Approval	Mar. 14, 2017

Secondary ID No.	JapicCTI-173528
Name of Other Registries

Countries / Regions of Recruitment	Japan

History of Changes

No	Publication date
6	Feb. 27, 2020	(this page)	Changes
5	Dec. 17, 2018	Detail	Changes
4	July. 10, 2017	Detail	Changes
3	July. 10, 2017	Detail	Changes
2	Mar. 07, 2017	Detail	Changes
1	Mar. 07, 2017	Detail

List of change history